Browse studies

Find your next paid study

9 recruiting studies matching your filters

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure (BENEFIT-HF)

The purpose of BENEFIT-HF is to demonstrate the safety and effectiveness of Baroreflex Activation Therapy (BAT) with the Barostim System in participants with h…

Heart FailureHeart Failure NYHA Class IIHeart Failure NYHA Class III

Estimated

~$10 – $8,750

CVRx, Inc.NCT07232030

Observational

A Prospective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II-III Heart Failure Patients

This is a prospective, multi-center, open label, randomized control clinical trial evaluating the safety and efficacy of the Cordella™ Pulmonary Artery Sensor …

Heart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure

Estimated

~$10 – $8,750

Endotronix, Inc.NCT05934487

Retrospective and Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System Via a Live Registry

The Yale HF Registry is a live EHR based registry that allows for retrospective and real-time monitoring of Heart Failure case across the Yale New Haven Health…

Heart FailureHeart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction+1 more

Estimated

~$10 – $750

Yale UniversityNCT04237701

The Real-World Effectiveness of The Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Failure: A Comparative Analysis to Standard of Care Pharmacologic Therapy

This retrospective, non-randomized cohort study will evaluate how well the Cordella PA Sensor System works compared to standard medication treatment in people …

Heart Failure NYHA Class IIIHeart Failure

Estimated

~$10 – $1,050

Endotronix, Inc.NCT06783335

Phase 2

Optimizing the Management of Patients With Heart Failure With Reduced Ejection Fraction Using BaroStim and CardioMems

The goal of this study is to utilize CardioMems (measurement of pulmonary artery diastolic pressure) to assess BaroStim. At the time of CardioMems insertion, p…

Heart Failure NYHA Class III

Estimated

~$10 – $7,500

Northwell HealthNCT07399587

Observational

A Novel Behavioral Intervention to Promote Adherence in Heart Failure

The focus of this study is to test the efficacy of a 12-week, phone-delivered Positive Psychology-Motivational Interviewing (PP-MI) intervention, with addition…

Heart FailureHeart Failure NYHA Class IHeart Failure NYHA Class II+1 more

Estimated

~$10 – $6,250

Massachusetts General HospitalNCT04829617

Phase 1

Safety and Feasibility of Autologous Induced Pluripotent Stem Cells of Cardiac Lineage in Subjects With Congenital Heart Disease

The goal of this clinical trial is to test the safety of lab-grown heart cells made from stem cells in subjects with congenital heart disease. The main questio…

Univentricular HeartCongenital Heart DiseaseHeart Failure NYHA Class III+1 more

Estimated

~$10 – $8,750

HeartWorks, Inc.NCT05647213

Observational

Sustaining Home Palliative Care for Patients With Heart Failure (HF) and Their Family Caregivers in Rural Appalachia: A Mixed Methods Randomized Clinical Trial (RCT).

The aim of this mixed methods randomized controlled trial is to test the integrated nurse-led intervention bundle for family home care management of end-stage …

Heart Failure NYHA Class IIIHeart Failure NYHA Class IV

Estimated

~$10 – $6,250

West Virginia UniversityNCT06791850

Observational

Randomized Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients

The use of implantable left ventricular assist devices (LVAD) has increased over the last decade; partly because the newer continuous flow pumps feature a smal…

Tricuspid RegurgitationHeart Failure NYHA Class IIIHeart Failure NYHA Class IV

Estimated

~$10 – $6,250

University of WashingtonNCT02537769